Tiverton Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Tiverton Asset Management's BLUE Position: Q4 2018 in Review
Tiverton Asset Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 884 shares — an estimated $1.67M sold.
Tiverton Asset Management first reported a position in BLUE in Q1 2016 and held it in 11 quarters. The position peaked at $12.9M in Q2 2016. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.
- Tiverton Asset Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
- Tiverton Asset Management sold 884 bluebird bio shares in Q4 2018, an estimated $1.67M.
- Tiverton Asset Management first reported a position in bluebird bio in Q1 2016 and held it in 11 quarters.
- Tiverton Asset Management's bluebird bio position peaked at $12.9M in Q2 2016.
- 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.
Based on Tiverton Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.